Skip to content

Clinical trials

Terminated Glioblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Status: Terminated Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20122
20141
20182
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AbbVie1
Amgen1
Incyte Corporation1
Isarna Therapeutics GmbH1
Martin-Luther-Universität Halle-Wittenberg1
Prof. Dr. Wolfgang Wick1
University Hospital Muenster1
photonamic GmbH & Co. KG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma10
Glioma4
Brain Neoplasms3
Astrocytoma2
Neoplasms2
Breast Neoplasms1
Central Nervous System Neoplasms1
Diffuse Intrinsic Pontine Glioma1
Gliosarcoma1
Oligodendroglioma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.